Emphasizing comprehensive enhancement of corporate value without setting specific management indicators
First written in FY2017. 5 of 7 entries say "Restated". Latest entry: 2026-05-12.
The whole theme swung hardest in 2023: 2 of 7 companies on the "Worse" side.
0 other companies' latest entry also says "Raised".
- 2026-05-12RaisedEarnings presentation materials
「More than ¥70 billion / More than 8%」
The company presented the quantitative levels of revenue exceeding ¥70 billion and ROE exceeding 8% in connection with its fiscal 2030 medium-term management policy. The original thread was not changed. - FY2024RestatedAnnual report
「Although we have not established specific management metrics, as a pharmaceutical manufacturer focused on prescription medicines, we are working to develop and ensure a stable supply of medicines that address growing and diversifying medical needs amid an aging society and advances in medical technology, as well as the public’s growing orientation toward health and welfare. Under the slogan “Better Medicines,” we are fulfilling our role as a member of the life sciences industry.」
The company continues to pursue a policy of prioritizing the development and stable supply of medicines and the comprehensive enhancement of corporate value without setting specific management metrics. - FY2022RestatedAnnual report
「Although we have not established specific management metrics, as a pharmaceutical manufacturer focused on prescription medicines, we are working to develop and ensure a stable supply of medicines that address growing and diversifying medical needs amid an aging society and advances in medical technology, as well as the public’s growing orientation toward health and welfare. Under the slogan “Better Medicines,” we are fulfilling our role as a member of the life sciences industry.」
The company continues to pursue a policy of comprehensively considering soundness, profitability, efficiency and growth without setting specific management metrics. - FY2021RestatedAnnual report
「Although we have not established specific management metrics, we place importance on the sustainable and stable enhancement of corporate value by comprehensively considering soundness, profitability, efficiency and growth.」
The company continues to pursue a policy of prioritizing sustainable and stable enhancement of corporate value from multiple perspectives without setting specific management metrics. - FY2019RestatedAnnual report
「Although we have not established specific management metrics, we place importance on the sustainable and stable enhancement of corporate value by comprehensively considering soundness, profitability, efficiency and growth.」
The company continues to pursue a policy of prioritizing sustainable and stable enhancement of corporate value from multiple perspectives without setting specific management metrics. - FY2018RestatedAnnual report
「Although we have not established specific management metrics, we place importance on the sustainable and stable enhancement of corporate value by comprehensively considering soundness, profitability, efficiency and growth.」
The company continues to pursue a policy of prioritizing sustainable and stable enhancement of corporate value from multiple perspectives without setting specific management metrics. - FY2017First statedAnnual report
「Although we have not established specific management metrics, we place importance on the sustainable and stable enhancement of corporate value by comprehensively considering soundness, profitability, efficiency and growth.」
The company has stated for the first time a policy of prioritizing sustainable and stable enhancement of corporate value by comprehensively considering soundness, profitability, efficiency and growth, without setting specific management metrics.